Tradr 2X Long SPY Quarte... SPYQ - Catena di Opzioni | ADVFN

Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Registrati

Home
Investire
ETFs
U.S.A.
NASDAQ
Tradr 2X Long SPY Quarterly ETF (SPYQ)
Tradr 2X Long SPY Quarterly ETF (SPYQ) Opzioni

Tradr 2X Long SPY Quarterly ETF (SPYQ)

23,4454

-0,10

(-0,43%)

Chiuso 20 Marzo 9:00PM

Ritardato di 15 minuti

23,4454

0,00

( 0,00% )

Pre Mercato: 12:28PM

Ritardato di 15 minuti

SPYQ Flusso Di Opzioni

Call

Strike	Denaro	Lettera	Ultimo Prezzo	Punto Medio	Var	Var %	Volume	INT APERTO	Ora Ultimo Ordine
15,00	5,40	10,40	0,00	7,90	0,00	0,00 %	0	0	-
16,00	4,40	9,40	0,00	6,90	0,00	0,00 %	0	0	-
17,00	3,40	8,40	0,00	5,90	0,00	0,00 %	0	0	-
18,00	2,40	7,40	0,00	4,90	0,00	0,00 %	0	0	-
19,00	1,40	6,40	0,00	3,90	0,00	0,00 %	0	0	-
20,00	0,45	5,30	0,00	2,875	0,00	0,00 %	0	0	-
21,00	0,30	4,40	0,00	2,35	0,00	0,00 %	0	0	-
22,00	0,90	3,50	0,00	2,20	0,00	0,00 %	0	0	-
23,00	0,25	2,40	0,00	1,325	0,00	0,00 %	0	0	-
24,00	0,05	0,05	0,54	0,05	-0,01	-1,82 %	2	23	20/3/2025
25,00	2,00	0,75	2,00	1,375	0,00	0,00 %	0	1	-
26,00	0,30	0,35	0,30	0,325	0,00	0,00 %	0	13	-
27,00	0,55	0,20	0,55	0,375	0,00	0,00 %	0	7	-
28,00	1,80	0,75	1,80	1,275	0,00	0,00 %	0	3	-
29,00	0,00	0,75	0,00	0,00	0,00	0,00 %	0	0	-
30,00	0,00	0,75	0,00	0,00	0,00	0,00 %	0	0	-
31,00	0,00	0,75	0,00	0,00	0,00	0,00 %	0	0	-
32,00	0,00	0,90	0,00	0,00	0,00	0,00 %	0	0	-

Strumenti di livello professionale, per investitori individuali

Put

Strike	Denaro	Lettera	Ultimo Prezzo	Punto Medio	Var	Var %	Volume	INT APERTO	Ora Ultimo Ordine
15,00	0,00	0,75	0,00	0,00	0,00	0,00 %	0	0	-
16,00	0,00	0,75	0,00	0,00	0,00	0,00 %	0	0	-
17,00	0,00	0,75	0,00	0,00	0,00	0,00 %	0	0	-
18,00	0,00	0,90	0,00	0,00	0,00	0,00 %	0	0	-
19,00	0,00	0,90	0,00	0,00	0,00	0,00 %	0	0	-
20,00	0,40	0,75	0,40	0,575	0,00	0,00 %	0	1	-
21,00	0,00	0,90	0,00	0,00	0,00	0,00 %	0	0	-
22,00	0,85	0,75	0,85	0,80	0,00	0,00 %	0	1	-
23,00	0,05	0,60	1,45	0,325	0,00	0,00 %	0	3	-
24,00	0,35	2,15	0,00	1,25	0,00	0,00 %	0	0	-
25,00	1,45	3,30	0,00	2,375	0,00	0,00 %	0	0	-
26,00	2,40	3,00	1,45	2,70	0,00	0,00 %	0	2	-
27,00	3,40	3,90	0,65	3,65	0,00	0,00 %	0	1	-
28,00	1,30	6,30	0,00	3,80	0,00	0,00 %	0	0	-
29,00	2,30	7,30	0,00	4,80	0,00	0,00 %	0	0	-
30,00	3,30	8,30	0,00	5,80	0,00	0,00 %	0	0	-
31,00	4,30	9,30	0,00	6,80	0,00	0,00 %	0	0	-
32,00	5,30	10,30	0,00	7,80	0,00	0,00 %	0	0	-

Più Attivi
% Guadagnanti
% Perdenti

Simbolo	Prezzo	Vol.
PNBKPatriot National Bancorp Inc	US$ 1,46 (37,74%)	6,96M
GCTKGlucoTrack Inc	US$ 0,5354 (29,48%)	29,92M
RNAZTransCode Therapeutics Inc	US$ 0,9799 (27,26%)	4,6M
RGCRegencell Bioscience Holdings Ltd	US$ 53,36 (18,58%)	78,14k
MCVTMill City Ventures III Ltd	US$ 2,15 (18,13%)	2,65k
DMNDamon Inc	US$ 0,0412 (-66,88%)	65,45M
RAASMI 3Fourteen REAL Asset Allocation ETF	US$ 15,01 (-38,31%)	3
FTCIFTC Solar Inc	US$ 1,75 (-35,90%)	315
STOKStoke Therapeutics Inc	US$ 6,21 (-25,45%)	14
IMVTImmunovant Inc	US$ 15,01 (-23,77%)	50
DMNDamon Inc	US$ 0,0412 (-66,88%)	65,45M
GCTKGlucoTrack Inc	US$ 0,5363 (29,70%)	29,92M
PNBKPatriot National Bancorp Inc	US$ 1,46 (37,74%)	6,96M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 8,20 (0,49%)	5,72M
RNAZTransCode Therapeutics Inc	US$ 0,9769 (26,87%)	4,6M

jammy32

jammy32 2 minuti fa

I’m very concerned about the PPS and the why. Nasrat has gone silent after placing a cap on the priice by saying it’s only worth 50 cents. Where is all the great news. Where is the support of the PPS. Why is MIKAH even an issue. Nasrat is waiting to long and I hope we don’t drop to single

SC8

SC8 2 minuti fa

No completely disagree. It's clear Indian human trials aren't run to the standards of USA human trials and they jumped the gun on both phase 1 and phase 2. There is no way FDA would have even allowed phase 1 if the dosing hadn't been worked out on controlled rabbit tumors first. MK's continued si

Rodney5

Rodney5 2 minuti fa

Good morning bcde,

Quote: “PSPA is authorized by HERA. No further Congressional approval is required as long as it is in compliance with HERA.” End of Quote

That’s the thing the preferred stock purchase agreement is not in compliance with HERA…

Neither

TheRealMrPirate

TheRealMrPirate 4 minuti fa

👍️👍️Huge value! Area code changer!

capgain

capgain 4 minuti fa

chipboarder

chipboarder 5 minuti fa

Looks like it’s happening! We need a press release to create some “coat-tails” so we can ride along.

Hoskuld

Hoskuld 5 minuti fa

Totally agree. I have something like a split mind when it comes to biotech investing: the part that puts the money to work is cynical and conservative and the other half of me is curious and excitable. I am very excited about the MAA and 3-71 schizophrenia trial - and still am cautious.

facts_matter14

facts_matter14 5 minuti fa

How are the E-Tricycle sales?????

It was featured at CES so it must be for sale by now, right?????

Raise your hand if you fell for that scam too.

.

EternalPatience

EternalPatience 6 minuti fa

We shall see. I know how human minds work to an extent..

getmenews

getmenews 6 minuti fa

MLBEF Latest News:

Fifty 1 Labs, Inc. (FITY), "Otherwise known as area 51" Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation

23 hours ago

Switched all my phones back to

amelia43

amelia43 7 minuti fa

Yeah that was when we couldn’t break $2’s. I sold all at around 88 cents after SCOTUS and lost a chunk of money. I was out of this stock for 2 years and then bought back a chunk at $1’s and another chunk at $3 exactly. My current average is $1.65 and new target is $10. I’m not greedy I just want

robinandthe7hoods

robinandthe7hoods 7 minuti fa

With Verses being a virtual company and having no overhead,other than salaries of low number of employees for a software company,Verses should be a cashcow going forward.
Genius has the ability to fit right into existing systems to save companies money,while saving them the time and exp

chereb19

chereb19 7 minuti fa

https://investorshub.advfn.com/uimage/uploads/2025/3/19/ecwtjScreenshot_2025-03-19-17-23-48-213_com.twitter.android-edit.jpg

georgie18

georgie18 8 minuti fa

AGH...89...Added here 🥳

georgie18

Member Level
Re: georgie18 post# 11

Thursday, March 20, 2025 1:49:38 PM

Post#
17
of 23
AGH...Added $1.02...🥳...Still looking for $1.75 plus...

g

chereb19

chereb19 8 minuti fa

What an incoherent statement.

Glad MK got you out of bed for nothing.

oldstocks

oldstocks 8 minuti fa

Dell markets OneMindNG

How much each company makes is unknown.

Here is what ai says:

Dell Technologies is actively promoting OneMindNG, a smart loT hypervisor solution developed by OneMind
Technologies. This platform is designed to simplify the int

georgie18

georgie18 8 minuti fa

AGH...89...Added here 🥳

georgie18

Member Level
Re: georgie18 post# 11

Thursday, March 20, 2025 1:49:38 PM

Post#
17
of 23
AGH...Added $1.02...🥳...Still looking for $1.75 plus...

g

georgie18

georgie18 9 minuti fa

AGH...89...Added here 🥳

georgie18

Member Level
Re: georgie18 post# 11

Thursday, March 20, 2025 1:49:38 PM

Post#
17
of 23
AGH...Added $1.02...🥳...Still looking for $1.75 plus...

g

Tahoe2468

Tahoe2468 9 minuti fa

MiamiGent

MiamiGent 9 minuti fa

Well written synopsis by Patricia Mccarthy of American Thinker

manibiotech

manibiotech 10 minuti fa

Let's see what happens Moreover another unknown in BO scenario is that if Advent is also bought out in the whole deal , what will be the valuation of , and how much of BO money will go to Advent

TJG

TJG 10 minuti fa

Exactly... I have no problem with flipping it...just dont want to get caught on the wrong side of news when it comes out...

trader_ron

trader_ron 10 minuti fa

$BRLL - To build an influential global portfolio of hospitality excellence by acquiring premier service-focused groups
https://www.dropbox.com/scl/fi/dav01zcjvc8wityyrskzp/Mainshire-Global-Project-2-2.pdf?rlkey=zidcn7f5z6gp2bvno7v4fl2kp&st=v6qjvmhp&dl=0

Tradr 2X Long SPY Quarte...

Delayed Upgrade Clock

Assistenza: support@advfn.it

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni